CXCL8 and non-small cell lung carcinoma: The observation of decreased IL-8 in NSCLC sera could potentially be due to the larger proportion of under-detection in normal compared to NSCLC subjects (56% vs. 23.81%, respectively; Figure 2B), as opposed to accurate differences in assayed values.